Christopher U. Missling, Director, President & CEO at ANAVEX LIFE SCIENCES CORP. (AVXL), bought 1,650 shares at $2.41 ($4K) on 2018-03-02, disclosed to the SEC on 2018-03-05.
Scheduled purchase ($4k) by Director, President & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| AVXL | SELL | 2021-07-01 | $1.3M | — | Filing → |
| AVXL | BUY | 2018-03-09 | $4K | — | Filing → |
| AVXL | BUY | 2018-03-07 | $4K | — | Filing → |